Deep Blue Medical Advances is a Duke University spin-out developing next-generation surgical devices for soft tissue repair and hernia surgery. Its platform centers on the T-Line Mesh, Suture, and Aesthetic Scaffold product lines, purpose-built to prevent suture pull-through and reinforce tissue during closure. Backed by 18 peer-reviewed publications and 21 issued patents, its lockstitch technology has been deployed in more than 20,000 implanted procedures across U.S. hospital systems.
1
Round
3
Tags
Apr 21, 2026
Latest raise
Funding activity · 1 round
Apr 21, 2026
$5.6M
Series A
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
